CDLX · Cardlytics, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.32M | - | $52.03M | $63.25M | $61.90M | - | $67.06M | $69.64M | $67.61M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $6.43M | - | $8.80M | $11.29M | $11.71M | - | $13.19M | $13.47M | $13.05M | - |
| SG&A | $8.28M | - | $10.85M | $12.90M | $13.78M | - | $12.08M | $16.15M | $14.48M | - |
| Total Operating Expenses | $42.59M | - | $120.89M | $76.04M | $75.98M | - | $215.60M | $85.45M | $90.43M | - |
| D&A | $4.42M | - | $6.47M | $6.28M | $6.29M | - | $6.97M | $6.53M | $6.25M | - |
| Operating Income | ($8.27M) | - | ($68.85M) | ($12.79M) | ($14.08M) | - | ($148.55M) | ($15.81M) | ($22.83M) | - |
| Interest Expense | $2.80M | - | $2.90M | $2.40M | $1.70M | - | - | - | $940.0K | - |
| Income Tax | $0 | - | - | - | - | - | - | - | - | - |
| Net Income | ($4.48M) | - | ($72.67M) | ($9.28M) | ($13.28M) | - | ($145.18M) | ($4.26M) | ($24.27M) | - |
| EPS - Basic | - | - | ($1.36) | ($0.18) | ($0.26) | - | ($2.90) | ($0.09) | ($0.56) | - |
| EPS - Diluted | - | - | ($1.36) | ($0.18) | ($0.26) | - | ($2.90) | ($0.09) | ($0.56) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35.67M | $48.72M | $43.96M | $46.74M | $52.05M | $65.59M | $66.99M | $71.25M | $97.77M | $91.83M |
| Accounts Receivable | $63.08M | $82.67M | $85.50M | $93.19M | $96.09M | $103.25M | $105.59M | $102.67M | $105.16M | $120.62M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $2.60M | $3.36M | $3.61M | $1.95M | $4.45M | $3.69M | $3.93M | $4.87M | $3.97M | $4.42M |
| Current Assets | $128.52M | $137.28M | $140.71M | $150.40M | $156.83M | $177.98M | $183.33M | $185.33M | $218.25M | $223.93M |
| Total Assets | $263.91M | $285.64M | $292.81M | $361.13M | $369.07M | $392.71M | $399.39M | $534.37M | $568.95M | $574.14M |
| Current Liabilities | $59.35M | $78.39M | $123.70M | $129.15M | $131.85M | $148.96M | $155.91M | $104.60M | $102.55M | $171.15M |
| Long-term Debt | $204.20M | $212.57M | $214.64M | $214.30M | $213.94M | $218.57M | $213.24M | $212.88M | $257.87M | - |
| Total Liabilities | $267.91M | $292.15M | $297.51M | $302.43M | $304.98M | $322.72M | $329.70M | $324.34M | $369.81M | $439.35M |
| Stockholders' Equity | ($4.00M) | ($6.51M) | ($4.70M) | $58.71M | $64.09M | $69.99M | $69.70M | $210.03M | $199.14M | $134.80M |
| Retained Earnings | ($1.41B) | ($1.40B) | ($1.40B) | ($1.32B) | ($1.31B) | ($1.30B) | ($1.28B) | ($1.14B) | ($1.14B) | ($1.11B) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($5.64M) | - | - | - | ($6.71M) | - | - | - | ($17.62M) | - |
| Investing Cash Flow | ($2.30M) | - | - | - | ($3.90M) | - | - | - | ($4.75M) | - |
| Financing Cash Flow | ($5.02M) | - | - | - | ($3.03M) | - | - | - | $28.32M | - |
| CapEx | $28.0K | - | - | - | $119.0K | - | - | - | $651.0K | - |
| Free Cash Flow | ($5.67M) | - | - | - | ($6.83M) | - | - | - | ($18.27M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -24.1% | - | -132.3% | -20.2% | -22.7% | - | -221.5% | -22.7% | -33.8% | - |
| EBITDA margin | -11.2% | - | -119.9% | -10.3% | -12.6% | - | -211.1% | -13.3% | -24.5% | - |
| Net margin | -13.1% | - | -139.7% | -14.7% | -21.5% | - | -216.5% | -6.1% | -35.9% | - |
| Free cash flow margin | -16.5% | - | - | - | -11.0% | - | - | - | -27.0% | - |
| FCF / Net income | 1.27 | - | - | - | 0.51 | - | - | - | 0.75 | - |
| R&D / Revenue | 18.7% | - | 16.9% | 17.9% | 18.9% | - | 19.7% | 19.3% | 19.3% | - |
| SG&A / Revenue | 24.1% | - | 20.9% | 20.4% | 22.3% | - | 18.0% | 23.2% | 21.4% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -1.7% | - | -24.8% | -2.6% | -3.6% | - | -36.4% | -0.8% | -4.3% | - |
| Return on equity | 111.9% | - | 1544.9% | -15.8% | -20.7% | - | -208.3% | -2.0% | -12.2% | - |
| Return on invested capital | -3.3% | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.17 | 1.75 | 1.14 | 1.16 | 1.19 | 1.19 | 1.18 | 1.77 | 2.13 | 1.31 |
| Quick ratio | 2.17 | 1.75 | 1.14 | 1.16 | 1.19 | 1.19 | 1.18 | 1.77 | 2.13 | 1.31 |
| Cash ratio | 0.60 | 0.62 | 0.36 | 0.36 | 0.39 | 0.44 | 0.43 | 0.68 | 0.95 | 0.54 |
| Leverage | ||||||||||
| Debt / Equity | -51.01 | -32.66 | -45.63 | 3.65 | 3.34 | 3.12 | 3.06 | 1.01 | 1.29 | - |
| Debt / Assets | 0.77 | 0.74 | 0.73 | 0.59 | 0.58 | 0.56 | 0.53 | 0.40 | 0.45 | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -3.0x | - | -23.7x | -5.3x | -8.3x | - | - | - | -24.3x | - |
| Equity multiplier | -65.93 | -43.89 | -62.25 | 6.15 | 5.76 | 5.61 | 5.73 | 2.54 | 2.86 | 4.26 |
| Liabilities / Assets | 1.02 | 1.02 | 1.02 | 0.84 | 0.83 | 0.82 | 0.83 | 0.61 | 0.65 | 0.77 |
| Efficiency | ||||||||||
| Asset turnover | 0.13 | - | 0.18 | 0.18 | 0.17 | - | 0.17 | 0.13 | 0.12 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 671d | - | 600d | 538d | 567d | - | 575d | 538d | 568d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | 1.5x | 1.5x | - | 2.3x | 1.4x | 3.1x | - |
| P / S | 1.7x | - | 2.5x | 1.4x | 1.5x | - | 2.4x | 4.1x | 9.3x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -44.6% | - | -22.4% | -9.2% | -8.4% | - | -15.1% | -9.2% | 5.1% | - |
| Revenue CAGR (3y) | -18.9% | - | -10.6% | -5.7% | -3.1% | - | 1.1% | - | 4.7% | - |
| Revenue CAGR (5y) | -10.2% | - | 2.5% | 17.5% | 6.3% | - | 3.5% | 7.4% | 13.4% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 41.2% | - | 53.6% | 19.1% | 38.3% | - | -619.3% | 35.0% | - | - |
| Net income growth (YoY) | 66.3% | - | 49.9% | -118.1% | 45.3% | - | -505.8% | 81.9% | - | - |
| EPS growth (YoY) | - | - | 53.1% | -100.0% | 53.6% | - | -360.3% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 16.9% | - | - | - | 62.6% | - | - | - | -75.2% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | -72.0% | -67.8% | -48.1% | -69.1% | -11.0% | -14.3% | -36.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$233.27M totalCardlytic Direct Segment$212.33M · 91.0%
Bridg Acquisition$20.95M · 9.0%
Product / service
$254.22M totalCostper Redemption$129.29M · 50.9%
Costper Served Sales$79.06M · 31.1%
Bridg Subscription Revenue$20.95M · 8.2%
Bridg Total Revenue$20.95M · 8.2%
Cost Other$3.97M · 1.6%
Geographic
$233.27M totalUS$202.97M · 87.0%
GB$30.30M · 13.0%
Peer comparison
Same SIC group: Services-Computer Programming, Data Processing, Etc.
Comparing Cardlytics against the 5 most active filers in the same SIC group.